Home » FDA Expands Recall of Medisca Drug After Mismatch Discovered
FDA Expands Recall of Medisca Drug After Mismatch Discovered
Troubled drug compounder and repackager Medisca has landed in hot water with the FDA again after the agency found a different type of drug in recalled lots of L-citrulline.
Drug Industry Daily
Drugs GMPs Quality Regulatory AffairsDrug Industry Daily
Upcoming Events
-
18Jul
-
21Oct